Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
NCT Number: NCT06624345
The goal of this clinical trial is to determine whether inspiratory muscle training aids in the recovery of respiratory muscle strength and helps prevent further muscle weakness in patients with myasthenia gravis.
The primary research questions are:
Does inspiratory muscle training enhance respiratory muscle strength recovery? Does the intervention lead to improved lung volumes? Participants underwent daily inspiratory muscle training and aerobic exercise for six consecutive weeks.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kaohsiung City, Taiwan
Patients with myasthenia gravis who experience acute exacerbations requiring hospitalization often suffer a significant decline in muscle strength, followed by partial recovery after the acute phase. This randomized controlled trial aims to evaluate the potential of early inspiratory muscle training and aerobic exercise in promoting muscle strength recovery and preventing further weakness. The study will assess differences in lung function, respiratory muscle strength, and dyspnea levels following the intervention after patients are discharged from the hospital post-acute exacerbation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in the IMT group received the intervention using a threshold loading device set at a pressure range of 5-39 cmH₂O. They were instructed to perform six sets of five breaths, totaling 30 breaths, twice daily for six weeks. Additionally, the aerobic exercise regimen included upper limb exercises (raising arms without resistance), a lower limb stepping warm-up, and a walking routine consisting of 5 minutes of slow walking, 2 minutes of brisk walking, and another 5 minutes of slow walking, for a total of 30 minutes per day.
Subjects received routine care.
Time frame: Six weeks
Maximum inspiratory pressure was measured by instructing each subject to exert their maximum inspiratory force against a pressure gauge.
Time frame: Six weeks
Dyspnea severity was assessed by a rating of perceived exertion, using the Borg Scale which ranged from 0 (no respiratory difficulty) to 10 (extreme respiratory difficulty), with higher scores indicating more severe breathing difficulty.
Time frame: Six weeks
The forced expiratory volume at one second was obtained, using spirometry, by having the patient take a deep breath and then exhale forcefully. The test results were based on three reproducible measurements.
Time frame: Six weeks
The peak expiratory flow was measured using a respiratory mechanics monitor during three forceful expirations.
Time frame: Six weeks
Maximum expiratory pressure was measured by instructing each subject to exert their maximum expiratory force against a pressure gauge.
Time frame: Six weeks
Forced vital capacity was measured using spirometry. Patients were instructed to take a deep breath and then exhale forcefully. The results were based on the average of three reproducible measurements.
Time frame: Six weeks
Patients were instructed to walk as fast as possible, while pulse oxygen saturation levels, heart rate, and Borg scale scores were monitored and recorded before, during, and after the test.
Chang Gung University
Other
Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07649187
Activities of Daily Living, Autoimmune Diseases
Taipei, Taiwan
View Trial DetailsNCT06002945
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Irvine, California, United States
View Trial DetailsNCT05332210
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06718855
Anxiety Disorders, Autoimmune Diseases
Milan, Italy
View Trial Details